Transcept (TSPT) Notified of ANDA Filing for Generic Intermezzo by Dr. Reddy's (RDY)
Tweet Send to a Friend
On February 21, 2013, Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT) received a new Paragraph IV notice letter from Dr. Reddy's Laboratories ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
